Skip to content

The Effect of Intra Articular Platelet Rich Plasma Injection in Knee Osteoarthritis

The Effect of Intra Articular Platelet Rich Plasma Injection in Knee Osteoarthritis - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081560
Enrollment
70
Registered
2025-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Group 1 - intra articular injection of platelet rich plasma: Patients will be recruited from the OPD after applying ACR criteria & KL Grade Il and Ill on X-RAY KNEE AP/LAT (STANDING) an

Sponsors

Teerthanker Mahaveer Medical College and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients over 18 years of age who had been diagnosed with osteoarthritis of the knee according to the American College of Rheumatology (ACR) 2019 criteria were included in this study. 2) Among these patients, only those diagnosed with Grade II and Grade III osteoarthritis of the knee joint, as classified by the Kellgren-Lawrence scale

Exclusion criteria

Exclusion criteria: a. Any known malignancy. b. Gouty Arthritis /inflammatory arthritis, Secondary Osteoarthritis c. Active knee infection. d. Disorders of Bleeding e. Uncontrolled Diabetes Mellitus f. Ligamentous instability of knee (MRI DIAGNOSED) g. Contraindication to MRI h. Any history of previous intraarticular steroid injection.

Design outcomes

Primary

MeasureTime frame
1. To assess and compare the functional outcome in patients of Knee Osteoarthritis before each PRP/NS Injection and at 6 months and at 9 months and study their effect. 2.To assess and compare the Radiological outcome with the help of WORMS score and X-Ray in patients of Knee Ostenarthritis and observe the chances at the end of 9 months.Timepoint: 1,2,6 and 9 month

Secondary

MeasureTime frame
To compare the change in biomarker of cartilage degeneration (serum Coll2-1No2)(8) values after IA PRP injection & IA NS injection with the clinical improvement seen after the intervention.Timepoint: 9 months;To compare the articular cartilage changes on specialized MRI sequences(WORMS)(9) before and after the interventionTimepoint: Before intervention and after 9 month

Countries

India

Contacts

Public ContactDr Amit Saraf
amitsaraf_75@yahoo.com9780029750

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026